Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
You searched for:
Search

Search

1-10 of 23 results
Results per page: 
Sort by: 
Outstanding performance by A&O in Global M&A league tables Outstanding performance by A&O in Global M&A league tables
04 October 2019
http://www.allenovery.com/publications/en-g … a-and-o-in-global-m-and-a-league-tables.aspx
Outstanding performance by A&O in Global M&A league tables 2019 Outstanding performance by A&O in Global M&A league tables 2019
04 October 2019
http://www.allenovery.com/news/en-gb/articl … e-by-a-and-o-in-global-ma-league-tables.aspx
​A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by number of FTSE 100 clients. The latest tables list A&O as advising 26 FTSE 100 clients. A&O has climbed the tables in the recently published Adviser Rankings league tables, ranking second by
06 September 2019
http://www.allenovery.com/news/en-gb/articl … strong-performance-in-ftse-100-rankings.aspx
This article discusses recommendations and next steps following the NICE draft guideline on prescribing cannabis-based medicinal products. This article discusses recommendations and next steps following the NICE draft guideline on prescribing cannabis-based medicinal products.
28 August 2019
http://www.allenovery.com/publications/en-g … eline-on-prescribing-medicinal-cannabis.aspx
​A&O, once again demonstrating our track record of acting on, and successfully completing, complex high-value transactions in a wide range of sectors and markets. A&O, once again demonstrating our track record of acting on, and successfully completing, complex high-value transactions in a wide
10 July 2018
http://www.allenovery.com/news/en-gb/articl … es-show-strength-of-AO’s-global-MA-team.aspx
A&O has marked the end of Q4 2018 with an extremely strong performance in the M&A league tables. A&O has marked the end of Q4 2018 with an extremely strong performance in the M&A league tables.
09 January 2019
http://www.allenovery.com/news/en-gb/articl … rmance-by-ao-in-global-ma-league-tables.aspx
In-house and external lawyers' attendance notes of conversations with employees of a client company who are not directly involved in instructing or receiving advice from the lawyers do not attract legal advice privilege.
13 December 2016
http://www.allenovery.com/publications/en-g … yers-notes-of-interviews-with-employees.aspx
In the first of a two-part update, Allen & Overy's Daniel Lim considers some of the key developments in CRISPR's increasingly complex IP patent and licensing landscape In the first of a two-part update, Allen & Overy's Daniel Lim considers some of the key developments in CRISPR's increasingly
12 December 2017
http://www.allenovery.com/publications/en-gb/Pages/Crowded-field.aspx
In January 2016, a year before the anticipated opening of the new Unified Patent Court, Allen & Overy’s patent litigators from seven of our European offices took part in two “mock” hearings before a fictional UPC court operating at our Brussels office.
08 February 2016
http://www.allenovery.com/news/en-gb/articl … trials-give-a-flavour-of-the-real-thing.aspx
In our latest article looking at a UPC scenario, Allen & Overy lawyers consider a case that raises questions about jurisdiction, discovery and Brexit. In our latest article looking at a UPC scenario, Allen & Overy lawyers consider a case that raises questions about jurisdiction, discovery and
01 May 2017
http://www.allenovery.com/publications/en-g … Brexit-and-the-UPC-a-fictional-scenario.aspx


  • Add comment (optional)